13F

Stock

Alnylam Pharmaceuticals, Inc.

ALNY · held by 7 managers

Reported value

$64.5M

Holders

7

+1 new · −0 exited

Holders’ est. mark

−$19.5M

Price effect on 5 books still in the name

Largest holder

$34.9M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC5.25M$34.9M−$22.3MAdded$1.36M
DANSKE BANK A/S52.4K$14.4M$1.68MAdded$1.7M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main12M$14M$1.1MAdded$289.2K
Swiss Life Asset Management Ltd3.62K$994.5K$61.9KAdded$521K
Prestige Wealth Management Group LLC451$124K$8.71KAdded$57.9K
Leonteq Securities AG95$26.1KNew

Positions as of Q3 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.